Screener
iRadimed IRMD Other Income (Expense)
Other Income (Expense) at other companies
Other financials
Where this comes from
Reported directly by iRadimed in its filing.
Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.
The source filing: iRadimed’s 10-Q, filed May 1, 2026.
- Filed
- May 1, 2026, 4:08 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-029325
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Research and development | 956 | 624 |
| Total operating expenses | 9,577 | 9,411 |
| Income from operations | 7,237 | 5,432 |
| Other income, net | 532 | 513 |
| Income before provision for income taxes | 7,769 | 5,945 |
| Provision for income tax expense | 1,951 | 1,258 |
| Net income | $5,818 | $4,687 |
| Net income per share: |
Item 1. Condensed Financial Statements
FAQ
- What is iRadimed's other income (expense)?
- iRadimed (IRMD) reported other income (expense) of $532K in Q1 2026.
- How has iRadimed's other income (expense) changed year-over-year?
- iRadimed's other income (expense) increased by 3.7% year-over-year, from $513K to $532K.
- What is the long-term trend for iRadimed's other income (expense)?
- Over 4 years (2021 to 2025), iRadimed's other income (expense) has grown at a 230.2% compound annual growth rate (CAGR), from $18.61K to $2.21M.
- What does other income (expense) mean?
- Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.
Ask your AI about iRadimed's other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude